Strategic Partnerships The Hamner Institutes actively grow through global partnerships with academia, industry, and government, presenting opportunities to propose collaborative research programs, sponsored studies, or joint grants with potential partners in life sciences and toxicology.

Toxicology Innovation With flagship programs in chemical safety sciences, drug safety sciences, and cutting-edge in silico and in vitro models, there is potential to offer services or platforms that complement their tool development, such as data analytics, computational modeling, or assay validation services.

Midmarket Scale As a nonprofit with 11-50 employees and revenue in the mid-range, The Hamner represents a collaboration-focused customer profile for modestly scoped projects, pilot studies, or cost-efficient CRADA-like engagements rather than large-scale outsourcing.

Health Outcomes Their mission to positively impact human health and emphasis on safety assessment tools create openings for consulting on regulatory strategy, risk assessment frameworks, and evidence generation to support safety submissions.

Digital & Data Current tech stack and emphasis on open, multidisciplinary research suggest opportunities to offer data integration, cloud-based collaboration tools, or analytics platforms that enhance their in silico and in vitro model workflows and project transparency.